MORGAN STANLEY - KURA ONCOLOGY INC ownership

KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 152 filers reported holding KURA ONCOLOGY INC in Q1 2022. The put-call ratio across all filers is 0.17 and the average weighting 0.3%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of KURA ONCOLOGY INC
ValueSharesWeighting
Q3 2023$1,467,982
-51.8%
160,963
-44.1%
0.00%
Q2 2023$3,044,151
+17.9%
287,727
+36.3%
0.00%
Q1 2023$2,581,093
-24.6%
211,046
-23.5%
0.00%
Q4 2022$3,422,578
-35.8%
275,792
-29.4%
0.00%
-100.0%
Q3 2022$5,334,000
-58.2%
390,508
-43.9%
0.00%
-50.0%
Q2 2022$12,753,000
+78.3%
695,800
+56.4%
0.00%
+100.0%
Q1 2022$7,154,000
+514.1%
444,840
+434.1%
0.00%
Q4 2021$1,165,000
-61.4%
83,289
-48.3%
0.00%
Q3 2021$3,015,000
-20.3%
161,027
-11.3%
0.00%
Q2 2021$3,785,000
+691.8%
181,511
+973.9%
0.00%
Q1 2021$478,000
-76.9%
16,902
-73.3%
0.00%
Q4 2020$2,065,000
+305.7%
63,240
+280.2%
0.00%
Q3 2020$509,000
+32.6%
16,633
-29.4%
0.00%
Q2 2020$384,000
+163.0%
23,558
+60.4%
0.00%
Q1 2020$146,000
-84.6%
14,684
-78.7%
0.00%
Q4 2019$949,000
+124.3%
69,081
+148.3%
0.00%
Q3 2019$423,000
-13.8%
27,820
+11.6%
0.00%
Q2 2019$491,000
+46.1%
24,928
+23.2%
0.00%
Q1 2019$336,000
-60.3%
20,240
-66.5%
0.00%
Q4 2018$846,000
-12.1%
60,328
+9.7%
0.00%
Q3 2018$963,000
-34.0%
55,014
-31.4%
0.00%
Q2 2018$1,460,000
+27.5%
80,211
+31.5%
0.00%
Q1 2018$1,145,000
-68.7%
61,000
-74.5%
0.00%
-100.0%
Q4 2017$3,663,000
+548.3%
239,382
+534.0%
0.00%
Q3 2017$565,000
-89.4%
37,756
-93.4%
0.00%
-100.0%
Q2 2017$5,321,000
-29.8%
572,223
-33.5%
0.00%
+100.0%
Q1 2017$7,576,000
+310.8%
860,856
+175.5%
0.00%
Q4 2016$1,844,000
+4188.4%
312,524
+4435.9%
0.00%
Q3 2016$43,000
+975.0%
6,890
+330.6%
0.00%
Q2 2016$4,0001,6000.00%
Other shareholders
KURA ONCOLOGY INC shareholders Q1 2022
NameSharesValueWeighting ↓
Foresite Capital Management IV, LLC 1,807,982$59,049,0006.41%
ACUTA CAPITAL PARTNERS, LLC 637,500$20,821,0005.67%
Asymmetry Capital Management, L.P. 346,518$11,317,0005.16%
Affinity Asset Advisors, LLC 260,000$8,492,0004.50%
EcoR1 Capital, LLC 1,773,037$57,907,0003.11%
VR Adviser, LLC 575,000$18,780,0002.76%
COMMODORE CAPITAL LP 133,503$4,360,0002.37%
Ghost Tree Capital, LLC 325,000$10,615,0002.36%
Avoro Capital Advisors LLC 4,000,000$130,640,0002.25%
SILVERARC CAPITAL MANAGEMENT, LLC 90,000$2,939,0001.71%
View complete list of KURA ONCOLOGY INC shareholders